Concepedia

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

Olivier Rixe, Waldo Ortuzar, Manuel Álvarez, R. R. Parker, Eddie Reed, K Paull, Tito Fojo

Biochemical Pharmacology · 1996 · 615 citations · 37 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyAntineoplastic Drug ClassesChemotherapy ResistanceCytotoxic ChemotherapyMalignant NeoplasmsOncology PharmacologyTherapeutic ResistanceAnticancer Drug ResistanceCombination Chemotherapy ResistanceOxaliplatin-based TherapyPlatinum-based RegimensResistance To Cell Cycle-targeted DrugsTherapeutic Drug Resistance

References

37

Cancer: Principles and Practice of Oncology.

Annals of Internal Medicine · 1991 · 8.5K citations

Medicine, Oncology, Oncology Nursing +10

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Ting‐Chao Chou, Paul Talalay · Advances in Enzyme Regulation · 1984 · 7.2K citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

Anne Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute · 1991 · 3.3K citations

Medicine, Oncology, Pharmacology +11

Cancer: Principles and Practice of Oncology

Walter G. Gunn · JAMA · 1994 · 1.8K citations

Medicine, Oncology, Oncology Nursing +10

Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm

Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes et al. · JNCI Journal of the National Cancer Institute · 1989 · 969 citations

Medicine, Biostatistics, Oncology +16